H.C. Wainwright


H.C. Wainwright Raises Price Target on Aurinia Pharmaceuticals Inc (AUPH) As Voclosporin Just Keeps Getting Better

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares are currently rising almost 8% after the biotech firm released the rare, good news that its drug in …

H.C. Wainwright Sings The Praises Of New Aurinia Pharmaceuticals Inc (AUPH) CEO

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) revealed yesterday evening that its Board of Directors has chosen Dr. Richard Glickman, the biotech firm’s founder and Chairman, …

H.C. Wainwright Dives In on Amarin Corporation plc (ADR) (AMRN) as REDUCE-IT Topline Data Within Sight

As REDUCE-IT continues to track to expected read-outs in early 2018, H.C.

H.C. Wainwright Chimes in on OHR Pharmaceutical Inc (OHRP) and the Implications of Fovista’s Failings

OHR Pharmaceutical Inc (NASDAQ:OHRP) is confronting the aftermath of Fovista’s pivotal two Phase 3 failures that both missed the primary endpoint in neovascular …

H.C. Wainwright’s Take On Nivalis Therapeutics Inc (NVLS) Clinical Trial Setback

Nivalis Therapeutics Inc (NASDAQ:NVLS) investors are heading for the hills after the drug maker reported that the Phase 2 study of cavosonstat as an …

H.C. Wainwright Weighs in on AEterna Zentaris Inc. (USA) (AEZS) Post Q3 Update

On November 9th, AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) posted third-quarter financial earnings and held a conference call.

H.C. Wainwright Cuts Price Target For Inovio Pharmaceuticals Inc (INO), But Remains Bullish

Inovio Pharmaceuticals Inc (NASDAQ:INO) released third-quarter financial earnings and a clinical progress update on the firm’s pipeline on Wednesday, November 9th. H.

H.C. Wainwright Believes Aurinia Pharmaceuticals Inc (AUPH) Wins Big with Results of End-of-Phase 2 Meeting with FDA

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) just scored what H.C.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts